Trial record 1 of 3 for:    TKM-080301
Previous Study | Return to List | Next Study

A Study to Determine Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM 080301 in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Arbutus Biopharma Corporation
ClinicalTrials.gov Identifier:
NCT01262235
First received: December 15, 2010
Last updated: August 27, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)